FDA Expands Approval for Antidepressant Nasal Spray

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression.Parkside Psychiatric Hospital has a Spravato outpatient clinic on-site and has seen more than 20 patients each week with positive results.It was initially approved in 2019 to treat resistant depression.FDA ApprovalSpravato is a nasal... Read More.

OSSAA Expands Football Playoffs

The Oklahoma Secondary School Activities Association (OSSAA) approved a proposal on Wednesday from the Oklahoma Football Coaches Association and the Oklahoma Interscholastic Athletic Administrators Association to add four teams to the playoffs in Classes 6A-I and 6A-II. As a result, each of the two districts in 6A-I and 6A-II will have six of the eight... Read More.